Dr. Raffi Tachdjian, MD

Dr. Tachdjian practices at Pacific Coast Plastic Surgery Center, Inc in Santa Monica, California.

Dr. Tachdjian's NPI, 1447376454, was assigned on March 21, 2007. Dr. Tachdjian graduated from Morehouse School Of Medicine in 2001. Dr. Tachdjian holds California license A88034.

Dr. Tachdjian's primary practice is Pacific Coast Plastic Surgery Center, Inc, at 1301 20th St, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 453-2733.

Dr. Tachdjian's primary practice is Pacific Coast Plastic Surgery Center, Inc in Santa Monica, California. The medical group on file is UCLA Health. Dmand AI also links Dr. Tachdjian to 1 more physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tachdjian practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Tachdjian's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Tachdjian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Tachdjian is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Tachdjian treats.

CMS data shows 13,386 Medicare services from Dr. Tachdjian across 11 procedure codes in 2024, for 194 Medicare patients. Medicare paid $133,699 for them. Every service was in an office.

CMS counts 194 Medicare patients who saw Dr. Tachdjian in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high cholesterol, and 58% have arthritis. 7% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tachdjian's median patient age at 37, with 57% women.

In 2024, Dr. Tachdjian wrote 81 Medicare Part D claims for 44 patients. 48% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $768 in total drug cost. In 2022, CMS named 107 claims across 7 drugs.

CMS lists Dr. Tachdjian as offering telehealth.

Dmand AI links 39 papers to Dr. Tachdjian, published from 2009 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Angioedemas, Hereditary, Complement C1 Inhibitor Protein and Double-Blind Method. Dr. Tachdjian has published most often in Allergy Asthma Proc. Dr. Tachdjian's most frequent co-authors are Timothy J. Craig, DO, William Raymond Lumry, MD and Marc Andrew Riedl, MD.

Dmand AI links Dr. Tachdjian to 6 clinical trials. Conditions studied include Hereditary Complement Deficiency Diseases, Angioedemas, Hereditary and Angioedema. Shire sponsors the most, 4. Open Payments lists research payments to Dr. Tachdjian that name 6 trials.

CMS Open Payments shows 5,440 general payments to Dr. Tachdjian from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. CSL Behring paid the most, $801,538. It also lists 51 research payments totaling $96,350 from 2021 to 2025, naming 6 clinical trials.

Dmand AI lists 2 awards for Dr. Tachdjian, most recently CMS Stage 1 EHR in 2013. Dr. Tachdjian serves on UCLA Pediatrics Committee.

Dr. Tachdjian graduated from Morehouse School Of Medicine in 2001. Dr. Tachdjian is a member of AAAAI and American College of Asthma Allergy and Immunology.

Dr. Tachdjian is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.